Steven Cohen's INCY Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 168,763 shares of Incyte Corporation (INCY) worth $15.88 M, representing 0.02% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in INCY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 2.37 M shares. Largest reduction occurred in Q3 2018, reducing 1.15 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Incyte Corporation (INCY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Incyte Corporation (INCY) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +168,763 | New Buy | 168,763 | $94.12 |
| Q4 2025 | -477,073 | Sold Out | 0 | $0.00 |
| Q3 2025 | -508,010 | Reduce 51.57% | 477,073 | $84.81 |
| Q2 2025 | +643,069 | Add 188.02% | 985,083 | $68.10 |
| Q1 2025 | -936,355 | Reduce 73.25% | 342,014 | $60.55 |
| Q4 2024 | -1.09 M | Reduce 46.04% | 1.28 M | $69.07 |
| Q3 2024 | +2.37 M | New Buy | 2.37 M | $66.10 |
| Q2 2024 | -380,100 | Sold Out | 0 | $0.00 |
| Q1 2024 | +380,100 | New Buy | 380,100 | $56.97 |
| Q1 2022 | -239,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +239,000 | New Buy | 239,000 | $73.40 |
| Q1 2021 | -487,700 | Sold Out | 0 | $0.00 |
| Q4 2020 | +226,689 | Add 86.85% | 487,700 | $86.98 |
| Q3 2020 | +261,011 | New Buy | 261,011 | $89.74 |
| Q2 2020 | -465,161 | Sold Out | 0 | $0.00 |
| Q1 2020 | +414,861 | Add 824.77% | 465,161 | $73.23 |
| Q4 2019 | +50,300 | New Buy | 50,300 | $87.32 |
| Q3 2019 | -200 | Sold Out | 0 | $0.00 |
| Q2 2019 | -76,039 | Reduce 99.74% | 200 | $85.00 |
| Q1 2019 | +1,778 | Add 2.39% | 76,239 | $86.01 |
| Q4 2018 | -70,877 | Reduce 48.77% | 74,461 | $63.59 |
| Q3 2018 | -1.15 M | Reduce 88.82% | 145,338 | $69.08 |
| Q2 2018 | +1.24 M | Add 2263.04% | 1.3 M | $67.00 |
| Q1 2018 | -15,000 | Reduce 21.43% | 55,000 | $83.33 |
| Q4 2017 | -94,600 | Reduce 57.47% | 70,000 | $94.71 |
| Q3 2017 | +144,600 | Add 723.00% | 164,600 | $116.74 |
| Q2 2017 | +5,400 | Add 36.99% | 20,000 | $125.90 |
| Q1 2017 | -424,201 | Reduce 96.67% | 14,600 | $133.70 |
| Q4 2016 | +370,801 | Add 545.30% | 438,801 | $100.27 |
| Q3 2016 | +68,000 | New Buy | 68,000 | $94.29 |
Steven Cohen's Incyte Corporation Investment FAQs
Steven Cohen first purchased Incyte Corporation (INCY) in Q3 2016, acquiring 68,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Incyte Corporation (INCY) for 30 quarters since Q3 2016.
Steven Cohen's largest addition to Incyte Corporation (INCY) was in Q3 2024, adding 2,369,300 shares worth $156.61 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 168,763 shares of Incyte Corporation (INCY), valued at approximately $15.88 M.
As of the Q1 2026 filing, Incyte Corporation (INCY) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Incyte Corporation (INCY) was 2,369,300 shares, as reported at the end of Q3 2024.